関連する実験動画
Updated: May 25, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
サブクリニック性甲状腺疾患
David S Cooper1, Bernadette Biondi
1Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. dscooper@jhmi.edu
Lancet (London, England)
|January 26, 2012
まとめ
軽度の甲状腺機能過剰症や甲状腺機能低下症を含むサブ臨床的甲状腺疾患は一般的であるが,その臨床的影響は不明である. これらの甲状腺機能障害の診断と治療を導くためにさらなる研究が必要である.
科学分野:
- エンドクリノロジー エンドクリノロジー
- 内科内科は,内科の内科である.
- 甲状腺学 甲状腺学について
背景:
- 軽度の甲状腺機能不全を特徴とするサブ臨床的甲状腺疾患は頻繁に発生します.
- サブクリニック性甲状腺機能過剰症およびサブクリニック性甲状腺機能低下症の臨床的意義と管理は,現在進行中の議論の対象となっています.
研究 の 目的:
- 準臨床的甲状腺疾患の定義,疫学,診断,進行をレビューする.
- サブクリニックの甲状腺機能不全の潜在的な健康結果と管理戦略について議論する.
- この分野における大規模なランダム化試験の必要性を強調する.
主な方法:
- 副臨床的な甲状腺疾患に関する現在の証拠の文献レビューと合成.
- 明らかに甲状腺疾患に進行するための診断基準とリスクの階層化の議論.
- 甲状腺を刺激するホルモンのレベルと併発性疾患に基づいた治療勧告の分析.
主要な成果:
- サブクリニカル型甲状腺疾患は,甲状腺の軽度の過剰活動または不活性を示し,臨床的影響は不明である.
- 副臨床的な甲状腺機能不全の治療の決定は,甲状腺刺激ホルモンの偏差の重症度と患者の併発性疾患に依存します.
- 現在の証拠は,管理を明確に導くには不十分であり,さらなる研究が必要である.
結論:
- サブクリニックの甲状腺疾患は一般的ですが,その臨床的意義についてはさらなる解明が必要です.
- 管理戦略は,個々の患者の要因と甲状腺機能障害の程度を考慮する必要があります.
- 大規模なランダム化対照試験は,サブ臨床的な甲状腺疾患の最適なケアガイドラインを確立するために不可欠です.
関連する概念動画
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...